Psyence Group (PSYG.C) started online sales and distribution for their Goodmind line of functional mushroom products today, according to a press release. These mushrooms make broad use of adaptogens,…
Wellness
BIOLASE Inc. (BIOL.Q) has announced its Q2 2021 Financial Results for the quarter ended June 30, 2021 and has provided Q3 2021 revenue guidance. “Our focus on educating and…
I am writing about Valeo Pharma Inc. at a very fascinating time for biotech/health stocks. Recently, Biotech has been hot! Led by the vaccine companies which are soaring. Just…
Back in January of this year, we told you about a psychedelics company that was going to come at that sector like many had talked about, but few had…
How many times a week do actors and actresses and other working folk on set have Q-tips rammed in their faces looking for COVID-19, do you think? I can’t…
Pure Extracts Technologies (PULL.C) subsidiary Pure Mushrooms submitted their class 3 license application to Health Canada’s Natural and Non-Prescription Health Products Directorate for the non-monograph claims of improvements to…
Most call centre work kills your soul. Long hours in cramped close quarters doing repetitive work, fielding questions that you’ve answered a million times before, and maybe hocking products…
Cognetivity Neurosciences (CGN.C) announced today that its Integrated Cognitive Assessment (ICA) will become an integral part of a new and highly innovative clinic in the UK’s Nation Health Service…
BioHarvest Sciences (BHSC.C) announces today that its Q2 2021 sales orders in Israel have reached USD$409,272 compared to $371,944 in Q1 2021 and $44,600 in Q2 2020. “As a…
Cybin (CYBN.NE) announced that they have entered into an exclusive research and development collaboration agreement with TMS NeuroHealth Centers, a wholly-owned subsidiary of Greenbrook TMS (GTMS.T). The agreement will…